Click here - to use the wp menu builder

Barri Blauvelt

Barri Blauvelt

Demonstrating Impact of Upstream Omnichannel Strategy on Downstream Results

by Barri M. Blauvelt, CEO, Innovara Upstream strategy used to be the domain of health care marketing. Today, it involves commercial, clinical research, access management,...

Barri Blauvelt - March 28, 2018

Recent Articles

Beckley Psytech Announces First Cohort Dosed in Phase 1 Clinical Trial Assessing Safety and Tolerability of Intranasal 5-MeO-DMT

Industry News October 25, 2021

Merck and Ridgeback Announce Initiation of a Rolling Review by the European Medicines Agency for Molnupiravir, an Investigational Oral Antiviral Medicine, for the Treatment...

Editor´s Pick October 25, 2021

Merck Announces Positive Top-Line Results from Pivotal Phase 3 Trials Evaluating Investigational, Once-Daily Oral Fixed Dose Combination of Doravirine/Islatravir for the Treatment of People...

Industry News October 25, 2021

Concert Pharmaceuticals Completes Enrollment in THRIVE-AA1 Phase 3 Clinical Trial Evaluating CTP-543 for Alopecia Areata

Industry News October 25, 2021

Kiromic BioPharma, Now Clinical Stage, Reports Significant Progression Free Survival Benefit in Metastatic Pancreatic Cancer Patient Treated with KiroVax/BSK01, Company’s Phase 1 Cell Therapy...

Industry News October 25, 2021

Arrowhead Files for Regulatory Clearance to Begin Phase 1/2a Study of ARO-C3 for Treatment of Complement Mediated Diseases

Industry News October 25, 2021

Applied DNA Submits Request for Emergency Use Authorization to FDA for Linea™ SARS-CoV-2 Mutation Panel

Regulatory Affairs October 25, 2021

Xeris Pharmaceuticals Enters Collaboration Agreement With Merck

Industry News October 25, 2021

Flare Therapeutics Appoints Daphne Karydas as COO and CFO, and Michaela Bowden, PhD, as SVP of Biology and Translation

Look Who’s On the Move! October 25, 2021

MIRROR Randomized Controlled Trial Meets Primary Endpoint and Shows 71% of Patients Achieved a Complete Response Rate Using KRYSTEXXA® (pegloticase injection) with Methotrexate

Industry News October 25, 2021

AnHeart Therapeutics Announces First Patient Dosed in Global Phase 2 TRUST-II Study for Taletrectinib in ROS1 Fusion-Positive Lung Cancer

Industry News October 25, 2021

Second Clinical Trial Collaboration Initiated to Evaluate Datopotamab Deruxtecan in Combination with KEYTRUDA® (pembrolizumab) in Patients with Metastatic Non-Small Cell Lung Cancer

Industry News October 25, 2021

Ferring Presents Award-Winning, Real-World Outcomes Analysis for Investigational Microbiota-Based Live Biotherapeutic, RBX2660, at ACG 2021

Industry News October 25, 2021

Moderna Announces Positive Top Line Data from Phase 2/3 Study of COVID-19 Vaccine in Children 6 to 11 Years of Age

Editor´s Pick October 25, 2021

Melinta Therapeutics Announces Appointment of Doug Girgenti as Vice President of Drug Development

Look Who’s On the Move! October 25, 2021